Skip to main content

UBS Group AG

Position in LENZ — LENZ Therapeutics, Inc.

CIK 1610520 ZURICH, V8

Position in LENZ

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$1,436,449
-$23,711,359 QoQ
Shares Held
156,989
-90.0% QoQ
Ownership
0.501%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority Sole 99.86368471676359.ToString("F0")% Shared 0.ToString("F0")% None 0.1363152832364051.ToString("F0")%

Common Shares in LENZ Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

UBS Group AG holds $8,296,969,172 across 554 Biotechnology names. LENZ ranks #228 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in LENZ

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,436,449 156,989
2025-12-31 $25,147,808 1,571,738
2025-09-30 $55,971,272 1,201,616
2025-06-30 $25,836,207 881,481
2025-03-31 $17,152,785 667,164
2024-12-31 $2,480,741 85,928
2024-09-30 $145,881 6,145
2024-06-30 $70,231 4,062
2024-03-31 $95,369 4,271